Quantification of in vivo site-specific Asp isomerization and Asn deamidation of mAbs in animal serum using IP-LC-MS.
about
2017 White Paper: rise of hybrid LBA/LCMS immunogenicity assays (Part 2: hybrid LBA/LCMS biotherapeutics, biomarkers & immunogenicity assays and regulatory agencies' inputs).Immunoaffinity MS: adding increased value through hybrid methods.Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions
P2860
Quantification of in vivo site-specific Asp isomerization and Asn deamidation of mAbs in animal serum using IP-LC-MS.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Quantification of in vivo site ...... n animal serum using IP-LC-MS.
@en
Quantification of in vivo site ...... n animal serum using IP-LC-MS.
@nl
type
label
Quantification of in vivo site ...... n animal serum using IP-LC-MS.
@en
Quantification of in vivo site ...... n animal serum using IP-LC-MS.
@nl
prefLabel
Quantification of in vivo site ...... n animal serum using IP-LC-MS.
@en
Quantification of in vivo site ...... n animal serum using IP-LC-MS.
@nl
P2093
P2860
P356
P1433
P1476
Quantification of in vivo site ...... n animal serum using IP-LC-MS.
@en
P2093
Alexander T Kozhich
Bogdan G Sleczka
Brenda Stevens
Christine S Huang
Deb G Gilbertson
Ekaterina G Deyanova
Eugene F Ciccimaro
Guodong Chen
Jingjie Mo
John T Mehl
P2860
P304
P356
10.4155/BIO-2016-0035
P577
2016-07-11T00:00:00Z